...
首页> 外文期刊>Journal of psychiatry & neuroscience: JPN >Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease.
【24h】

Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease.

机译:脑脊髓液中总tau和磷酸化tau 181蛋白水平与轻度认知障碍和阿尔茨海默病中脑萎缩的关系。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: We sought to examine the association of levels of total tau (t-tau) and phosphorylated tau 181 (p-tau181) protein with brain morphology in mild cognitive impairment, as defined by the concept of aging-associated cognitive decline (AACD) and Alzheimer disease. METHODS: Twenty-three participants with AACD, 16 with Alzheimer disease and 15 healthy controls underwent magnetic resonance imaging and lumbar puncture. We performed voxel-based morphometry to investigate the association between tau levels in cerebrospinal fluid (CSF) and cerebral grey matter density throughout the entire brain. RESULTS: Voxel-based morphometry revealed that both elevated t-tau and p-tau181 concentrations were associated with reduced grey matter density in temporal, parietal and frontal regions. Among participants with AACD, elevated levels of p-tau181 (but not t-tau) in CSF were correlated with a pronounced atrophy in the right hippocampus. LIMITATIONS: Our study was limited by the small sample, especially with respect to the analysis comprising the AACD subgroups. Moreover, we did not correct our voxel-based morphometry analyses for multiple dependent comparisons, therefore they harbour a risk of false-positive results. CONCLUSION: Elevated levels of t-tau and p-tau181 in CSF reflect degenerative processes in the cortical regions typically affected in Alzheimer disease. Our findings in participants with AACD support the hypothesis that p-tau181 might be more specifically related to neurodegenerative changes in early Alzheimer disease.
机译:背景:我们试图研究轻度认知障碍中总tau(t-tau)和磷酸化tau 181(p-tau181)蛋白水平与脑形态的关系,这是由衰老相关的认知功能减退(AACD)概念定义的和阿尔茨海默氏病。方法:23名AACD患者,16名阿尔茨海默氏病患者和15名健康对照者进行了磁共振成像和腰椎穿刺。我们进行了基于体素的形态测量,以研究脑脊液(CSF)中tau水平与整个大脑中脑灰质密度之间的关系。结果:基于体素的形态测定显示,t-tau和p-tau181浓度升高均与颞,顶和额叶区域灰质密度降低有关。在患有AACD的参与者中,脑脊液中p-tau181(而非t-tau)水平升高与右海马区明显萎缩相关。局限性:我们的研究受到小样本样本的限制,特别是在包含AACD亚组的分析方面。此外,我们没有针对多个相关的比较对基于体素的形态分析进行校正,因此它们存在产生假阳性结果的风险。结论:脑脊液中t-tau和p-tau181的水平升高反映了通常受阿尔茨海默病影响的皮质区域的退化过程。我们在AACD参与者中的发现支持以下假设:p-tau181可能与早期阿尔茨海默氏病的神经退行性改变更具体相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号